| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |